Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71610-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71610 0022 45

71610 0022 45
Label for Atorvastatin Calcium 20 mg film-coated tablets, containing 45 tablets per container. The label includes storage instructions to keep between 20-25 degrees Celsius and keep out of reach of children. It shows the labeler as Aphena Pharma Solutions - Tennessee, LLC, with manufacturing by Apotex Inc., Ontario, Canada. The label is for oral prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph comparing cumulative incidence percentages over a period of 3.5 years for Atorvastatin and placebo groups. The graph shows Atorvastatin with a solid line and placebo with a dashed line, indicating lower cumulative incidence in the Atorvastatin group. Statistical values including a hazard ratio (HR=0.64) and p-value (0.0005) are displayed below the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A Kaplan-Meier plot comparing cumulative hazard (%) over time (years) up to 4 years for placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentages. The plot includes a hazard ratio (HR) of 0.63 with 95% confidence interval (0.48-0.83) and p-value 0.001, indicating lower risk with atorvastatin compared to placebo.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph depicting the percentage of subjects experiencing a cardiovascular event over a five-year period. It compares two doses of atorvastatin, 10 mg (dashed line) and 80 mg (solid line), showing the lower event rate with the 80 mg dose. The graph includes a hazard ratio (HR 0.78) with confidence intervals and a p-value, indicating statistical analysis of the data.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of atorvastatin calcium, depicting the molecular arrangement of the active ingredient in this prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.